Catherine Chung

1.4k total citations
87 papers, 881 citations indexed

About

Catherine Chung is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Catherine Chung has authored 87 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Dermatology, 24 papers in Epidemiology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Catherine Chung's work include Cutaneous lymphoproliferative disorders research (19 papers), Lymphoma Diagnosis and Treatment (10 papers) and Drug-Induced Adverse Reactions (10 papers). Catherine Chung is often cited by papers focused on Cutaneous lymphoproliferative disorders research (19 papers), Lymphoma Diagnosis and Treatment (10 papers) and Drug-Induced Adverse Reactions (10 papers). Catherine Chung collaborates with scholars based in United States, Canada and Australia. Catherine Chung's co-authors include Otoniel Martı́nez-Maza, Joanna M. Watson, Jonathan S. Berek, Reba M. Knox, Brian Poligone, Roberto G. Melano, Benjamin H. Kaffenberger, Samir N. Patel, Klaus F. Helm and Kate S. Hutson and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Catherine Chung

80 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Chung United States 14 217 181 172 157 136 87 881
Marlies Mulder Netherlands 17 159 0.7× 402 2.2× 51 0.3× 21 0.1× 67 0.5× 35 940
Ikuo Murata Japan 20 137 0.6× 163 0.9× 134 0.8× 22 0.1× 23 0.2× 90 1.4k
Osamu Imataki Japan 18 342 1.6× 127 0.7× 193 1.1× 19 0.1× 12 0.1× 135 1.1k
Hoon Kook South Korea 22 260 1.2× 559 3.1× 546 3.2× 17 0.1× 7 0.1× 131 1.8k
Matthew Shale United Kingdom 11 214 1.0× 137 0.8× 245 1.4× 43 0.3× 5 0.0× 14 1.0k
F Châtelet France 13 255 1.2× 131 0.7× 75 0.4× 45 0.3× 22 0.2× 29 868
Katsuhiro Miura Japan 12 175 0.8× 113 0.6× 50 0.3× 34 0.2× 19 0.1× 81 538
Soo Min Kim South Korea 13 105 0.5× 111 0.6× 207 1.2× 81 0.5× 10 0.1× 45 580
Andrea Mengarelli Italy 19 279 1.3× 199 1.1× 171 1.0× 10 0.1× 41 0.3× 64 1.0k

Countries citing papers authored by Catherine Chung

Since Specialization
Citations

This map shows the geographic impact of Catherine Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Chung more than expected).

Fields of papers citing papers by Catherine Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Chung. The network helps show where Catherine Chung may publish in the future.

Co-authorship network of co-authors of Catherine Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Chung. A scholar is included among the top collaborators of Catherine Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Chung. Catherine Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chung, Catherine, et al.. (2024). Immune checkpoint inhibitor induced bullous pemphigoid treated by dupilumab: A case series. JAAD Case Reports. 57. 90–94.
3.
Reneau, John, et al.. (2024). Final Results of a Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas. Blood. 144(Supplement 1). 4438–4438. 1 indexed citations
4.
Redman, Charles, et al.. (2024). Graduate medical education success coaching for residents and fellows: a single-institution real-world experience. Medical Education Online. 29(1). 2342102–2342102. 2 indexed citations
5.
Chung, Catherine, et al.. (2024). Papulonodular mucinosis with features of discoid lupus erythematosus. JAAD Case Reports. 45. 59–61. 1 indexed citations
6.
Huang, Ying, et al.. (2024). Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas. Archives of Dermatological Research. 316(5). 199–199. 1 indexed citations
7.
Bharti, Vijaya, N. Roy-Chowdhury, Daniel de Lima Bellan, et al.. (2024). TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING. JCI Insight. 9(15). 5 indexed citations
8.
Kaffenberger, Benjamin H., Catherine Chung, Eric Samorodnitsky, et al.. (2024). Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib. Haematologica. 109(11). 3816–3820. 1 indexed citations
9.
Gray, Ashley, Catherine Chung, Lucia Seminario‐Vidal, et al.. (2023). Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil. JAAD Case Reports. 36. 82–88. 2 indexed citations
10.
Trinidad, John, et al.. (2023). Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology. International Journal of Dermatology. 62(8). 1034–1039. 2 indexed citations
11.
Bharti, Vijaya, Amrendra Kumar, Rebecca L. Shattuck-Brandt, et al.. (2022). BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. Cell Reports. 41(12). 111826–111826. 29 indexed citations
12.
Schwarz, Emily, Lianbo Yu, Paolo Fadda, et al.. (2022). Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma. Journal of Investigative Dermatology. 143(4). 630–638.e3. 2 indexed citations
13.
Korman, Abraham M., et al.. (2022). Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis. Journal of the American Academy of Dermatology. 88(5). 1142–1145. 2 indexed citations
14.
Trinidad, John, et al.. (2022). Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study. American Journal of Clinical Dermatology. 24(2). 299–304. 4 indexed citations
15.
Chung, Catherine, et al.. (2021). Grading of differentiation in cutaneous squamous cell carcinoma: Evaluation of interrater and intrarater reliability. Journal of the American Academy of Dermatology. 87(4). 895–897. 2 indexed citations
16.
Schwarz, Emily, John H. Howard, Lianbo Yu, et al.. (2021). Loss of miR-1469 expression mediates melanoma cell migration and invasion. PLoS ONE. 16(9). e0256629–e0256629. 4 indexed citations
17.
Plaza, Jose A., Thomas Brenn, Catherine Chung, et al.. (2020). Histomorphological and immunophenotypical spectrum of cutaneous myoepitheliomas: A series of 35 cases. Journal of Cutaneous Pathology. 48(7). 847–855. 8 indexed citations
18.
Chung, Catherine, et al.. (2020). Solar Lentigo Evolving into Fatal Metastatic Melanoma in a Patient Who Initially Refused Surgery. ScholarSphere (Penn State Libraries). 14(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026